An Observational Study of CPT-11 Plus Platinum Analogues Regimens and UGT1A1 Genotypes in Solid Tumors

NCT01040312 · clinicaltrials.gov ↗

COMPLETED

Status

321

Enrollment

INDUSTRY

Sponsor class

Conditions

Small Cell Lung Cancer
Non-small Cell Lung Cancer
Cervical Cancer
Ovarian Cancer
Gastric Cancer (Inoperable and Recurrent)

Interventions

DRUG: CPT-11
DRUG: Platinum analogues

Sponsor

Daiichi Sankyo Co., Ltd.